CSE:AGN - Post Discussion
Post by
StockHawk1 on Mar 02, 2023 5:27pm
AGN appoints TBI expert for TBI-DMT study
Algernon Pharmaceuticals Inc. (AGN.c AGNPF) has appointed Global TBI Expert, Dr. David L. Brody as a consultant for its TBI-DMT clinical research program.
Brody was a Professor of Neurology and director of the NFL Neurological player care program at Washington University.
Good to see that AGN's study of using DMT to treat TBI will be backed by such expertise.
https://finance.yahoo.com/news/algernon-neuroscience-appoints-global-tbi-130000428.html
Be the first to comment on this post